Richard Chin

Insider Reports History

Location
C/O Oxigene, Inc., 230 Third Avenue, Waltham, MA
Signature
/s/ Valerie Barnett, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Chin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cytek Biosciences, Inc. Director Common Stock 4.07K $16.9K $4.15 Aug 18, 2025 Direct
Cytek Biosciences, Inc. Director Restricted Stock Units 69.2K Aug 18, 2025 Direct
Cytek Biosciences, Inc. Director Director Stock Option (right to buy) 39.1K Jun 18, 2025 Direct
Kindred Biosciences, Inc. Chief Executive Officer, Director Common Stock 0 $9.25 Aug 27, 2021 By reporting person as custodian for daughter
Kindred Biosciences, Inc. Chief Executive Officer, Director Common Stock 0 $9.25 Aug 27, 2021 By reporting person as custodian for son
Kindred Biosciences, Inc. Chief Executive Officer, Director Common Stock 0 $9.25 Aug 27, 2021 Direct
Kindred Biosciences, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 $4.81 Aug 27, 2021 Direct

Insider Reports Filed by Richard Chin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTKB Cytek Biosciences, Inc. Aug 18, 2025 2 $0 4 Aug 20, 2025 Director
CTKB Cytek Biosciences, Inc. Jun 18, 2025 2 $0 4 Jun 20, 2025 Director
CTKB Cytek Biosciences, Inc. Jun 18, 2025 0 $0 3 Jun 20, 2025 Director
KIN Kindred Biosciences, Inc. Aug 27, 2021 14 -$23.6M 4 Aug 30, 2021 Chief Executive Officer, Director
KIN Kindred Biosciences, Inc. Aug 2, 2021 2 -$368K 4 Aug 4, 2021 Chief Executive Officer, Director
KIN Kindred Biosciences, Inc. Jul 2, 2021 1 -$367K 4 Jul 7, 2021 Chief Executive Officer, Director
KIN Kindred Biosciences, Inc. Jun 16, 2021 1 -$367K 4 Jun 17, 2021 Chief Executive Officer, Director